Industry Growth Insights published a new data on “Companion Animal Pharmaceutical Market”. The research report is titled “Companion Animal Pharmaceutical Market research by Types (Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027, Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications), By Applications (Dogs, Cats, Other), By Players/Companies Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Parnell”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Companion Animal Pharmaceutical Market Research Report
By Type
Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027, Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications
By Application
Dogs, Cats, Other
By Companies
Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Parnell
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Companion Animal Pharmaceutical Market Report Segments:
The global Companion Animal Pharmaceutical market is segmented on the basis of:
Types
Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027, Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs, Cats, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Boehringer Ingelheim
- Merck Animal Health
- Elanco Animal Health
- Bayer Animal Health
- Virbac
- Dechra Veterinary Products
- Ceva
- Vetoquinol
- Meiji
- Ouro Fino Saude
- Parnell
Highlights of The Companion Animal Pharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
- Infectious Diseases
- Dermatologic Diseases
- Pain
- Orthopedic Diseases
- Behavioral Diseases
- Other Indications
- By Application:
- Dogs
- Cats
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Companion Animal Pharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Companion Animal Pharmaceutical is a term used to describe veterinary pharmaceuticals specifically designed for companion animals. These products may be prescribed by veterinarians to treat specific health conditions in pets, or they may be marketed as pet supplements.
Some of the major players in the companion animal pharmaceutical market are Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Parnell.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Companion Animal Pharmaceutical Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Companion Animal Pharmaceutical Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Companion Animal Pharmaceutical Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Companion Animal Pharmaceutical Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Companion Animal Pharmaceutical Market Size & Forecast, 2018-2028
4.5.1 Companion Animal Pharmaceutical Market Size and Y-o-Y Growth
4.5.2 Companion Animal Pharmaceutical Market Absolute $ Opportunity
Chapter 5 Global Companion Animal Pharmaceutical Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Companion Animal Pharmaceutical Market Size Forecast by Type
5.2.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
5.2.2 Infectious Diseases
5.2.3 Dermatologic Diseases
5.2.4 Pain
5.2.5 Orthopedic Diseases
5.2.6 Behavioral Diseases
5.2.7 Other Indications
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Companion Animal Pharmaceutical Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Companion Animal Pharmaceutical Market Size Forecast by Applications
6.2.1 Dogs
6.2.2 Cats
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Companion Animal Pharmaceutical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Companion Animal Pharmaceutical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Companion Animal Pharmaceutical Analysis and Forecast
9.1 Introduction
9.2 North America Companion Animal Pharmaceutical Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Companion Animal Pharmaceutical Market Size Forecast by Type
9.6.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
9.6.2 Infectious Diseases
9.6.3 Dermatologic Diseases
9.6.4 Pain
9.6.5 Orthopedic Diseases
9.6.6 Behavioral Diseases
9.6.7 Other Indications
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Companion Animal Pharmaceutical Market Size Forecast by Applications
9.10.1 Dogs
9.10.2 Cats
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Companion Animal Pharmaceutical Analysis and Forecast
10.1 Introduction
10.2 Europe Companion Animal Pharmaceutical Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Companion Animal Pharmaceutical Market Size Forecast by Type
10.6.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
10.6.2 Infectious Diseases
10.6.3 Dermatologic Diseases
10.6.4 Pain
10.6.5 Orthopedic Diseases
10.6.6 Behavioral Diseases
10.6.7 Other Indications
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Companion Animal Pharmaceutical Market Size Forecast by Applications
10.10.1 Dogs
10.10.2 Cats
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Companion Animal Pharmaceutical Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Companion Animal Pharmaceutical Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Companion Animal Pharmaceutical Market Size Forecast by Type
11.6.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
11.6.2 Infectious Diseases
11.6.3 Dermatologic Diseases
11.6.4 Pain
11.6.5 Orthopedic Diseases
11.6.6 Behavioral Diseases
11.6.7 Other Indications
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Companion Animal Pharmaceutical Market Size Forecast by Applications
11.10.1 Dogs
11.10.2 Cats
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Companion Animal Pharmaceutical Analysis and Forecast
12.1 Introduction
12.2 Latin America Companion Animal Pharmaceutical Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Companion Animal Pharmaceutical Market Size Forecast by Type
12.6.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
12.6.2 Infectious Diseases
12.6.3 Dermatologic Diseases
12.6.4 Pain
12.6.5 Orthopedic Diseases
12.6.6 Behavioral Diseases
12.6.7 Other Indications
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Companion Animal Pharmaceutical Market Size Forecast by Applications
12.10.1 Dogs
12.10.2 Cats
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Companion Animal Pharmaceutical Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Companion Animal Pharmaceutical Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Companion Animal Pharmaceutical Market Size Forecast by Type
13.6.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
13.6.2 Infectious Diseases
13.6.3 Dermatologic Diseases
13.6.4 Pain
13.6.5 Orthopedic Diseases
13.6.6 Behavioral Diseases
13.6.7 Other Indications
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Companion Animal Pharmaceutical Market Size Forecast by Applications
13.10.1 Dogs
13.10.2 Cats
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Companion Animal Pharmaceutical Market: Competitive Dashboard
14.2 Global Companion Animal Pharmaceutical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Boehringer Ingelheim
14.3.3 Merck Animal Health
14.3.4 Elanco Animal Health
14.3.5 Bayer Animal Health
14.3.6 Virbac
14.3.7 Dechra Veterinary Products
14.3.8 Ceva
14.3.9 Vetoquinol
14.3.10 Meiji
14.3.11 Ouro Fino Saude
14.3.12 Parnell
